CG-400549
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- CG-400549
- DrugBank Accession Number
- DB12347
- Background
CG400549 has been used in trials studying the treatment of Skin Infection.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 340.439
Monoisotopic: 340.124548584 - Chemical Formula
- C19H20N2O2S
- Synonyms
- Not Available
- External IDs
- CG400549
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Toluenes
- Direct Parent
- Aminotoluenes
- Alternative Parents
- Aniline and substituted anilines / Pyridinones / Dihydropyridines / Alkyl aryl ethers / Vinylogous esters / Thiophenes / Heteroaromatic compounds / Lactams / Azacyclic compounds / Primary amines show 2 more
- Substituents
- Alkyl aryl ether / Amine / Aminotoluene / Aniline or substituted anilines / Aromatic heteromonocyclic compound / Azacycle / Dihydropyridine / Ether / Heteroaromatic compound / Hydrocarbon derivative show 13 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4X6T64D64X
- CAS number
- 934628-27-0
- InChI Key
- YCLREGRRHGLOAK-UHFFFAOYSA-N
- InChI
- InChI=1S/C19H20N2O2S/c1-14-15(4-2-6-18(14)20)13-21-9-7-16(12-19(21)22)23-10-8-17-5-3-11-24-17/h2-7,9,11-12H,8,10,13,20H2,1H3
- IUPAC Name
- 1-[(3-amino-2-methylphenyl)methyl]-4-[2-(thiophen-2-yl)ethoxy]-1,2-dihydropyridin-2-one
- SMILES
- CC1=C(CN2C=CC(OCCC3=CC=CS3)=CC2=O)C=CC=C1N
References
- General References
- Not Available
- External Links
- PubChem Compound
- 11844916
- PubChem Substance
- 347828603
- ChemSpider
- 10019391
- BindingDB
- 231620
- ChEMBL
- CHEMBL488937
- ZINC
- ZINC000016696900
- PDBe Ligand
- PT6
- PDB Entries
- 4cv0 / 4cv1 / 4cv2
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Skin Infections 1 1 Completed Treatment Healthy Volunteers (HV) 2
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00718 mg/mL ALOGPS logP 3.57 ALOGPS logP 3.29 Chemaxon logS -4.7 ALOGPS pKa (Strongest Basic) 4.01 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 55.56 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 100.31 m3·mol-1 Chemaxon Polarizability 36.47 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-0209000000-cbc8ddca4e72e843bd7e Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-000j-6039000000-9744698d01b7d5703ee3 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-00dl-0549000000-d9666254fe14271719a1 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-01t9-1290000000-1d438b7d03e192dab7eb Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-05fr-1900000000-a822b90b3b55bb0f6081 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-07es-2920000000-89bc05de70513515d535 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 184.0423046 predictedDarkChem Lite v0.1.0 [M-H]- 170.24893 predictedDeepCCS 1.0 (2019) [M+H]+ 184.6387046 predictedDarkChem Lite v0.1.0 [M+H]+ 172.60693 predictedDeepCCS 1.0 (2019) [M+Na]+ 184.4347046 predictedDarkChem Lite v0.1.0 [M+Na]+ 179.37242 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 22:02 / Updated at June 12, 2020 16:53